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Objectives: In Qataris, a population characterized by a small size and a high rate of consanguinity, between
two-thirds to three-quarters of adults are overweight or obese. We investigated the relevance of 23 obesity-related
loci in the Qatari population.
Methods: Eight-hundred-four individuals assessed to be third generation Qataris were included in the study
and assigned to 3 groups according to their body mass index (BMI): 190 lean (BMI < 25 kg/m2); 131 overweight
(25 kg/m2 ≤ BMI < 30 kg/m2) and 483 obese (BMI ≥ 30 kg/m2). Genomic DNA was isolated from peripheral blood
and genotyped by TaqMan.
Results: Two loci significantly associated with obesity in Qataris: the TFAP2B variation (rs987237) (A allele versus G
allele: chi-square = 10.3; P = 0.0013) and GNPDA2 variation (rs10938397) (A allele versus G allele: chi-square = 6.15;
P = 0.013). The TFAP2B GG genotype negatively associated with obesity (OR = 0.21; P = 0.0031). Conversely, the
GNDPA2 GG homozygous genotype associated with higher risk of obesity in subjects of age < 32 years (P = 0.0358).
Conclusion: We showed a different genetic profile associated with obesity in the Qatari population compared to
Western populations. Studying the genetic background of Qataris is of primary importance as the etiology of a given
disease might be population-specific.
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Obesity is a medical condition characterized by an accu-
mulation of excess of body fat, which eventually results in
a reduced life expectancy and/or increased health prob-
lems. Obesity frequently associates with dyslipidemia,
hypertension, insulin resistance, type 2 diabetes mellitus
(T2DM) and cardiovascular diseases [1]. Adipocyte-
specific metabolic differences have been described in
literature [2]. The incidence and prevalence of obesity
are rising rapidly to epidemic proportions both in the
industrial world and worldwide. Obesity results from an* Correspondence: stomei@sidra.org; loc2008@qatar-med.cornell.edu
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unless otherwise stated.imbalance between energy intake and energy expend-
iture. As a multifactorial disease, its onset is due to the
interplay between environmental and genetic factors.
Environmental risk factors include the use of dense fast
food, sugar-sweetened beverages, large portion sizes, a
sedentary behavior, physical inactivity and shortened
sleep period [3]. In parallel, genetic factors also contribute
to the etiology of obesity [4]. Although cases of monogenic
obesity (caused by mutations in single genes) have been
described in literature [5], obesity in mainly polygenic.
Polygenic obesity results from a complex interaction be-
tween multiple genes and the environment. Although
these genes do not directly cause obesity, they can influ-
ence obesity development in certain environments and/or
in concert with other genetic alterations. Several GWASThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(SNPs) associated to obesity and fat distribution [6-10].
While current studies provide data about obesity risk
factors, they have been mainly focused on Western pop-
ulations and their conclusions do not necessarily apply to
populations with a different genetic background. Clearly,
additional research is warranted to better understand
obesity risk factors in populations disproportionately
affected by obesity like the Qatari population.
In Qataris, a population characterized by a very small
size with a particularly high rate of consanguinity, which
can reach 54% due to frequent first-degree cousin unions
[11], more than 70% of the adult population is overweight
or obese [12]. Such a high rate of obesity has been attrib-
uted to the lifestyle changes associated with the discovery
of oil and the subsequent increase in wealth. Urbanization
has occurred rapidly in Qatar and has been accompanied
by the acquisition of a sedentary lifestyle, which may have
contributed to the increased obesity incidence and preva-
lence. Recent GWAS studies have identified genetic
factors predisposing/protecting to obesity; however, it
is not well known whether these genetic markers confer
similar or different risks across people of different
ancestry. Although an uneven distribution of disease-
associated alleles between populations of different an-
cestry has been shown for recessive Mendelian disorders
[13,14], whether this phenomenon applies also to complex
diseases is not yet well understood. Markers identified by
GWAS studies may confer a risk, which can vary accord-
ing to the different ancestry of the populations under
study. This phenomenon can be due to the variability of
allelic frequencies and/or to differences in linkage disequi-
librium (LD) between the identified variants and the true
functional variants that underlie disease risk [15,16].
In this regard, a recent study interestingly showed that
the genetic risk for type 2 diabetes and pancreatic can-
cer decreased as humans migrated toward East Asia,
highlighting a genetic risk differentiation of multifactor-
ial diseases across human populations [17].
In this report we selected 23 loci found associated to
obesity in previous studies and tested them in the Qatari
population. This question is particularly relevant consider-
ing that little is known about the genetic background of the
Arabian populations. When selecting the SNPs to test, we
aimed at choosing the ones mapping within or in proximity
of well documented obesity genes (as FTO and MC4R, for
instance) and as representative of the obesity status (both
in terms of BMI and waist circumference). These 23 SNPs
included 19 loci associated to BMI (of which 11 were re-
cently identified) [9,10,18-21] and 4 loci associated to body
weight and waist circumference [9,18,22].
The phenotype/genotype interaction was also investi-
gated by analyzing the association of the obesity SNPs
with phenotypic and clinical parameters.The genetic investigation of diversity in human phys-
ical characteristics has a rich history and several ancestry
informative markers (AIM), defined as human polymor-
phisms that exhibit substantially different frequencies
among populations, have been identified and proved able
to discriminate human populations [23]. However, the
weight played by variations associated to multifactorial
diseases (like obesity) in discriminating human popula-
tions has been poorly investigated.
By comparing the 23 SNPs genotyping data from our
cohort of Qatari lean subjects with the data from the
1000Genomes Project, we show here that such disease-
related loci are able to differentiate ethnically different
human populations to a lesser extent when applied to
Qataris, most likely due to their heterogeneity as Qataris
derive from populations of different genetic background.
Materials and methods
Subjects’ recruitment
A total of 804 Qatari subjects with no known familial rela-
tionship were recruited from the health clinic at Hamad
Medical Corporation Hospital, Doha, Qatar, on a voluntary
basis. The study was approved by the Research Ethics Com-
mittee of Hamad Medical Corporation and by Institutional
Review Board of Weill Cornell Medical College in Qatar.
All the subjects who agreed to participate in this study gave
informed consent prior to their inclusion in the study. Only
individuals assessed to be third generation Qataris (as
reported by questionnaires) were included in the study.
Individuals were assigned to three different groups accord-
ing to their body mass index (BMI), as following:
– 190 lean (BMI < 25 kg/m2);
– 131 overweight (25 kg/m2 ≤ BMI < 30 kg/m2);
– 483 obese (BMI ≥ 30 kg/m2).
For the association purposes, only lean and obese
group were included in the analysis. The lean group in-
cluded 124 (65%) female and 66 (35%) male subjects.
The obese group included 378 (78%) female and 105
(22%) male subjects. The average ages were 31.36 and
48.06 for the lean and obese groups, respectively.
Phenotypic and clinical variables assessment
WC (waist circumference, cm) was measured midway
between the lowest rib and the superior border of the
iliac crest on standing subjects by a single examiner
using an inelastic tape. BMI was calculated as weight
(kg) divided by the squared height (m2). A questionnaire
solicited information about age, gender, parent and
grandparent ethnicity, sleep hours and the presence of
sleep disorders. The presence or absence of cardiovas-
cular diseases, T2DM and cholesterol disorders was also
recorded.
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some cases only partial data was available as some subjects
refused to answer all the items in the questionnaires.
DNA isolation
A 10 mL blood sample was collected in sterile sodium hep-
arin collection tubes for each individual recruited in the
study. Genomic DNA was isolated from peripheral blood
samples using QIAamp® DNA Blood Maxi Kit according
to the manufacturer’s protocol (Qiagen, Valencia, CA).
DNA quality and quantity were estimated using Nanodrop
(Thermo Scientific, Waltham, Massachusetts, USA).
Genotyping
Twenty-three SNPs reported as obesity-related in previous
studies were selected and genotyped using TaqMan tech-
nology. TaqMan pre-designed SNP genotyping assays were
chosen from Applied Biosystems website (https://product-
s.appliedbiosystems.com/ab/en/US/adirect/ab). Quantita-
tive Real-Time PCR (qPCR) was performed in a final
volume of 25 uL containing the TaqMan® Universal PCR
Master Mix (without AmpErase® UNG), the SNP Geno-
typing Assay Mix (SNP assay-specific) and 10–50 ng of
genomic DNA. Each pre-formulated SNP Genotyping
Assay Mix included the forward and reverse primers
(900 nM final concentration), and the VIC- and 6FAM-
conjugated probes (200 nM final concentration) which
detected the two alternative alleles, respectively. QPCR
was carried out on a 7500 Fast Real-Time PCR System
machine (Applied Biosystems, Grand Island, NY). Each
PCR reaction used distilled water instead of DNA as
negative control. The thermal cycling conditions were as
follows: initial denaturing at 95°C for 10 min, 40 cycles of
92°C for 15 s and 60°C for 1 min.
After PCR amplification, an endpoint plate read was
performed. Fluorescence measurements obtained during
the plate read were used by the Sequence Detection
System (SDS) Software to plot fluorescence (Rn) values
based on the signals from each single plate well. Results
were plotted on a two-dimensional scatter plot of the
major allele versus the minor allele. Genotyping calls
were assessed based on the allele discrimination plots
and manually reviewed by looking at the single amplifi-
cation plots.
Statistical analyses
We compared the baseline characteristics of the partici-
pants using analysis of variance tests (ANOVA) for con-
tinuous variables. Categorical variables were analyzed
using the chi-square test. Mean BMI values were esti-
mated within each group of homozygous reference,
heterozygous, and homozygous variant genotypes for each
SNP. The mean BMI estimates were adjusted by age and
gender using analysis of covariance (ANCOVA) approach.Multivariable logistic regression analysis was performed
to estimate odds ratios (ORs) adjusted for covariates
and to assess the predictive effect of each SNP on risk
of developing obesity. Data is reported as mean ± stand-
ard deviation (SD) and range, unless stated otherwise.
All statistical assessments were two-sided and consid-
ered to be significant when P-value < 0.05. All analyses
were performed using SAS (version 9.4; SAS Institute,
Cary, NC). Hardy-Weinberg equilibrium (HWE) was
tested by chi-square.
Genotyping data for the 23 SNPs under study were
downloaded from the 1000Genomes Project website
(http://www.1000genomes.org/) from Africans (61 ASW,
American of African Ancestry in South West USA; 97
LWK, Luhya in Webuye, Kenya; 88 YRI, Yoruba in
Ibadan, Nigeria), Americans (60 CLM, Colombians from
Medellin, Colombia; 66 MXL, Mexican Ancestry from
Los Angeles, USA; 55 PUR, Puerto Ricans from Puerto
Rico), Asians (97 CHB, Han Chinese in Bejing, China; 100
CHS, Southern Han Chinese; 89 JPT, Japanese in Tokyo,
Japan), Europeans (85 CEU, Utah Residents (CEPH)
with Northern and Western European ancestry; 93 FIN,
Finnish in Finland; 89 GBR, British in England and
Scotland; 14 IBS, Iberian population in Spain; 98 TSI,
Toscani in Italy). In the American MXL population,
offspring genotypes (n = 2) were removed to analyze
unrelated subjects. Unphased genotyping data from the
1000Genomes Project and healthy Qatari lean subjects
was used for Principal Component Analysis (PCA)
visualization. PCA plots are presented based on Partek
Genomic Suite software. PCA was performed by using
the “Super Population Codes” for graphical purposes,
namely, AFR for Africans, ASN for Asian, EUR for
Europeans, AMR for Americans. Qatari lean subjects
were called QAR when performing PCA.
Results
General characteristics of Qatari populations
Table 1 shows the phenotypic and clinical characteristics
of lean, overweight and obese subjects. As expected, the
presence of CVD, T2DM and cholesterol disorders was
significantly higher in obese compared to lean subjects.
WC was also significantly associated to the obese group
compared to the lean group. A nominal difference was
found in sleeping hours between obese and lean, with the
former showing a sleep trend toward “less than 8 hours”.
Analysis of the obesity susceptibility loci in Qataris
The 23 obesity susceptibility loci selected for this study
are listed in Additional file 1: Table S1.
Out of the 23 SNPs assessed, only two were signifi-
cantly associated to obesity in Qataris, namely rs987237
and rs10938397. No deviations from Hardy-Weinberg
equilibrium were detected.
Table 1 Phenotypic and clinical parameters of lean, overweight and obese Qatari subjects
Phenotypic/clinical parameter Lean Overweight Obese P-value (comparing obese vs. lean)
Sex (M/F) 66/124 44/87 105/378 0.0008
Age (y ± SD) 31.37 ± 13.5 35.93 ± 13.6 48.06 ± 13.4 <0.0001
BMI (kg/m2 ± SD) 22.2 ± 2.1 27.6 ± 1.4 36.2 ± 5.6 <0.0001
WC (cm ± SD) 78.7 ± 9.1 91.8 ± 7.4 106.1 ± 13.0 <0.0001
Sleep hours (A/B/C) 37/93/25 35/76/18 82/123/27 0.04
Sleep disorders (Y/N) 42/101 37/87 77/151 0.42
CVD (Y/N) 6/150 24/103 74/159 <0.0001
T2DM (Y/N) 4/152 23/105 68/162 <0.0001
Cholesterol disorder (Y/N) 8/147 27/100 89/144 <0.0001
M, male; F, female; SD, standard deviation; BMI, body mass index; WC, waist circumference; Sleep hours (A/B/C), A, less than 6 hours, B, between 6 and 8 hours, C,
more than 8 hours; Y, yes (presence); N, no (absence); CVD, cardiovascular diseases; T2DM, type 2 diabetes mellitus.
P values were calculated comparing obese vs. lean only, Fisher and Student’s t tests were applied as appropriate.
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obesity is shown in Table 2 and Table 3, respectively. Only
lean and obese individuals were included in the analysis
and tested under three models, namely: unadjusted, ad-
justed for age and adjusted for age and gender.
The frequencies of rs987237 A and G alleles were
respectively 0.77 and 0.23 in lean and 0.84 and 0.16 in
obese subjects.
The frequencies of rs10938397 A and G alleles were
respectively 0.72 and 0.28 in lean and 0.64 and 0.36 in
obese subjects.
When evaluating the association of rs987237 to obesity
under the model adjusted for age and gender, the GG
genotype was associated with a protective role (GG versus
AA, P = 0.0031). This observation contrasts with findings
from other reports which show a predisposing role in
populations with different ethnicities [9,22]. The AA,
AG and GG genotypes showed a gradient in BMI for
the rs987237 (Figure 1).
In agreement with previous reports, rs10938397 GG
genotype showed a predisposing effect with an almost
2-fold increased risk of obesity in GG carriers com-
pared to the AA genotype. Although this association
did not reach statistical significance [9,22,24], when
breaking down all the individuals tested in age tertilesTable 2 Multiple logistic regression models for obesity
for the rs987237 SNP
Models Rs987237 (n = 673)
AA, n = 459* AG, n = 187 GG, n = 27 P-trend
Obese n = 341 Obese n = 130 Obese n = 11
Model 1 1 0.79 (0.54-1.15) 0.24 (0.11-0.53) 0.0014
Model 2 1 0.65 (0.42-1.01) 0.20 (0.07-0.56) 0.0029
Model 3 1 0.65 (0.42-1.01) 0.21 (0.08-0.57) 0.0031
Model 1: unadjusted; Model 2: adjusted for age; Model 3: adjusted for
gender + Model 2.
A allele versus G allele, chi-square = 10.3; P = 0.0013.
*The analysis of one sample among the cases failed for rs987237 SNP.(< 32 years, ≥ 32 years and < 51 years, ≥ 51 years), the
association became significant in the youngest group
(age < 32 years, p = 0.0358) (Figure 2).
Additional file 1: Tables S2 and S3 show the distribution
of rs987237 and rs10938397 genotypes, respectively ac-
cording to the specific clinical and phenotypic variables.
The genetic signature of the Qatari population as defined
by the 23 obesity SNPs
We compared the allele distribution of the 23 obesity SNPs
in lean Qatari population with that of the 1000 Genomes
Project.
Albeit these 23 SNPs were able to discriminate the major
genetic groups (African, Asian and Caucasian), we found a
general admixture of Qatari individuals with subjects of
European as well as African and Asian origin although to
a lesser extent (Figure 3A). This could reflect the different
tribal ancestries of the Qatari population.
As for the only two SNPs which turned out to be signifi-
cant in the Qatari population, their frequency was different
from the frequencies of the other populations (Figure 3B).
Discussion
Obesity has become a major global health problem to-
gether with all the complications and diseases associated
with body fat accumulation. Although the increasingTable 3 Multiple logistic regression models for obesity
for the rs10938397 SNP
Models Rs10938397 (n = 674)
AA, n = 302 AG, n = 292 GG, n = 80 P-trend
Obese n = 206 Obese n = 210 Obese n = 67
Model 1 1 1.19 (0.84-1.70) 2.40 (1.27-4.56) 0.0266
Model 2 1 1.02 (0.68-1.54) 1.67 (0.82-03.40) 0.3532
Model 3 1 1.06 (0.70 -1.61) 1.65 (0.81-3.36) 0.3885
Model 1: unadjusted; Model 2: adjusted for age; Model 3: adjusted for
gender + Model 2.
A allele versus G allele, chi-square = 6.15; P = 0.013.
Figure 1 BMI distribution of the AA, AG and GG genotypes for the
rs987237 SNP. Error bars indicate standard deviation.
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antly explained by lifestyle changes (high intake of fast
food and less physical activity), yet some individuals
seem to be more susceptible to obesity than others
highlighting an important genetic component. Unfortu-
nately, to date no studies are available to dissect the gen-
etic component of obesity in the Qatari population. In
the current study we evaluated whether previously
established obesity loci associate to obesity also in the
Qatari population. Toward this aim, we selected 23
SNPs which have been related to BMI and waist cir-
cumference in previous GWAS studies [9,10,18-22].
These SNPs were chosen as representative of the obes-
ity status in Western populations (as no comprehensive
studies are available yet for the Arabian populations) and
because close or within genes whose association to obesity
has been well established (e.g., FTO, MC4R). Studying the
effect of these 23 SNPs becomes important considering that
little is known about the predisposition to obesity in Qataris.
Unexpectedly, only 2 of the 23 SNPs tested were sig-
nificantly associated with obesity, namely rs987237 and
rs10938397.
The rs987237 SNP maps in the TFAP2B gene. TFAP2B
encodes a transcription factor, which is expressedFigure 2 BMI distribution of the AA, AG and GG genotypes for the rs10938
y (B), age Age ≥ 51 y (C). Error bars indicate standard deviation.preferentially in adipose tissue. Its role in regulating the
adipocyte function and adipokine expression is believed to
be responsible for the functional link to obesity [22,25]. It
has been shown that overexpression of TFAP2B results in
lipid accumulation by enhancing glucose transport and in-
ducing insulin resistance [25,26] and decreases the secre-
tion of adiponectine and leptin in human adypocites
[25,27]. The TFAP2B rs987237 SNP has been found asso-
ciated with WC and BMI in a meta-analysis study which
included 16 GWAS of subjects of European ancestry [22].
In the present study, the rs987237 G allele showed a sig-
nificant association with protection to obesity, however
the direction of the effect was opposite to that reported
initially [9,22]. Opposite direction on the effect of a
given allele has been observed in several studies either
among different populations or within the same popula-
tion [28,29]. In the case of rs987237, the opposite direc-
tion has been reported in a recent study from
Albuquerque and colleagues which showed a nominal
association of the rs987237 A allele with the risk of
obesity in a population of Portuguese children [30]. Fur-
ther studies with a larger sample size of Qatari individ-
uals are needed to confirm these findings.
As for rs10938397 SNP, we found a significant contribu-
tion of the minor allele of rs10938397 to increased risk of
obesity in individuals of age < 32 years. This SNP maps
near GNPDA2 gene, which encodes the glucosamine-6-
phosphate isomerase, an enzyme involved in the carbohy-
drate metabolism. The association between GNPDA2 and
BMI has firstly been identified in a meta-analysis of several
European GWAS performed by the GIANT consortium
[10,24]. Subsequently, the association has been confirmed
in other populations of adults from East-Asia and of
Chinese population [31,32]. However, our study is the
first to evaluate the association of this SNP in Qataris.
Notably, the association reached significance only in
individuals of age < 32 years. The reason behind the
age-related association is not clear, lifetime environ-
mental and/or body composition changes may explain
such phenomenon. The findings from a recent study397 SNP according to the age tertiles: age < 32 y (A), 32 y ≤ age < 51
Figure 3 Comparison of African (AFR), Asian (ASN), American (AMR), European (EUR) and Qatari (QAR) population data. Principal
component analysis (PCA) based on the 23 obesity loci (A). Distribution of rs987237 and rs10938397 allelic frequencies among World
populations (B).
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support our findings and provide rationale for further
investigation [33]. Alternatively, it is possible that the
sample size of our cohort did not have enough power to
detect association in older individuals. Further studies
are necessary to validate our results.
With regards to the other variations, it should be
stated that the fact that we did not find association with
SNPs within or near well-known obesity predisposing
genes (i.e., FTO and MC4R) might indicate that loci
other than the ones we tested in our study might have a
role in predisposing to obesity in Qataris.
Targeted replication studies of FTO gene in African
and African Americans have yielded inconsistent results,
potentially due to the difference in linkage disequilib-
rium (LD) structure between FTO SNPs in African com-
pared with European or Asian ancestry populations, as
reviewed by Loos RJF and Yeo GSH [34].
Although FTO is most probably the strongest and best
replicated obesity gene [7,34], different GWAS studies for
obesity-related traits in populations with European ancestry
identified different FTO SNPs [20,21,34], with rs9939609
most commonly associated to obesity. All GWAS-identified FTO SNPs belong to the same highly corre-
lated cluster, which covers about 46 kb in the first
intron of FTO (including rs1558902). The cluster of
BMI-associated FTO SNPs in East Asian populations is
very similar to that of European ancestry populations.
However, in populations of African ancestry, the correl-
ation between SNPs in the first intron of FTO is much
weaker than in those with European ancestry (Additional
file 2: Figure S1). As we do not know much about the LD
architecture of the Qatari genome, we cannot exclude that
rs1558902 SNP may be in a different LD block from the
one that includes the real FTO functional variation.
Interestingly, concordant to our findings, a study from
Shimaoka and colleagues failed to demonstrate statistical
association of the FTO rs1558902 SNP in a cohort of
almost one thousand five hundred Japanese subjects [35].
Furthermore, rs1421025 SNP located in intron 1 of the
FTO gene (as rs1558902 tested in this study) showed
absence of association to obesity in Mexican children [24].
Replication of the association of these 23 SNPs in
Qataris is not obvious and ethnic differences in linkage
disequilibrium patterns, ethnicity-specific associations and
gene-environment interactions may cloud the picture.
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cate our findings.
It is noteworthy that these 23 established genetic
variations associated with obesity explain very little of
the genetic risk for the Qatari population, suggesting the
existence of additional loci whose number and effect size
remain unknown and which should be the focus of future
more intense investigation.
High-throughput technologies, including whole gen-
ome sequencing and chip-based genotyping on an ex-
tended number of lean and obese Qatari subjects would
help in identifying additional loci and should be consid-
ered as a useful strategy.Conclusions
Our data support a different genetic profile associated
with obesity in the Qatari population compared to Western
populations, as only 2 among 23 SNPs have been found
associated to obesity in the Qatari population. Studying the
genetic background of Qataris is of primary importance as
the etiology of a given disease might be population-specific.Additional files
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